Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Apr;99(4):483-489.e2.
doi: 10.1016/j.gie.2023.11.053. Epub 2024 Feb 26.

Physician perceptions on the current and future impact of artificial intelligence to the field of gastroenterology

Affiliations
Practice Guideline

Physician perceptions on the current and future impact of artificial intelligence to the field of gastroenterology

Prepared by: ASGE AI Task Force et al. Gastrointest Endosc. 2024 Apr.

Abstract

Background and aims: The use of artificial intelligence (AI) has transformative implications to the practice of gastroenterology and endoscopy. The aims of this study were to understand the perceptions of the gastroenterology community toward AI and to identify potential barriers for adoption.

Methods: A 16-question online survey exploring perceptions on the current and future implications of AI to the field of gastroenterology was developed by the American Society for Gastrointestinal Endoscopy AI Task Force and distributed to national and international society members. Participant demographic information including age, sex, experience level, and practice setting was collected. Descriptive statistics were used to summarize survey findings, and a Pearson χ2 analysis was performed to determine the association between participant demographic information and perceptions of AI.

Results: Of 10,162 invited gastroenterologists, 374 completed the survey. The mean age of participants was 46 years (standard deviation, 12), and 299 participants (80.0%) were men. One hundred seventy-nine participants (47.9%) had >10 years of practice experience, with nearly half working in the community setting. Only 25 participants (6.7%) reported the current use of AI in their clinical practice. Most participants (95.5%) believed that AI solutions will have a positive impact in their practice. One hundred seventy-six participants (47.1%) believed that AI will make clinical duties more technical but will also ease the burden of the electronic medical record (54.0%). The top 3 areas where AI was predicted to be most influential were endoscopic lesion detection (65.3%), endoscopic lesion characterization (65.8%), and quality metrics (32.6%). Participants voiced a desire for education on topics such as the clinical use of AI applications (64.4%), the advantages and limitations of AI applications (57.0%), and the technical methodology of AI (44.7%). Most participants (42.8%) expressed that the cost of AI implementation should be covered by their hospital. Demographic characteristics significantly associated with this perception included participants' years in practice and practice setting.

Conclusions: Gastroenterologists have an overall positive perception regarding the use of AI in clinical practice but voiced concerns regarding its technical aspects and coverage of costs associated with implementation. Further education on the clinical use of AI applications with understanding of the advantages and limitations appears to be valuable in promoting adoption.

PubMed Disclaimer

Conflict of interest statement

Disclosure The following authors disclosed financial relationships: C. Leggett: Consultant for Verily Life Sciences. S. Parasa: Consultant for Medtronic and Microsoft Research; advisory board for the Allen Institute for Artificial Intelligence and Fujifilm; research support from Fujifilm. A. Repici: Research support from Fujifilm, Boston Scientific Corporation, and Norgine; speaker for Boston Scientific Corporation and Norgine. T. Berzin: Consultant for Medtronic, Wision AI, Magentiq Eye, RSIP Vision, and Docbot AI. S. Gross: Consultant for Medtronic and Iterative Scopes. P. Sharma: Consultant for Bausch, Boston Scientific Corporation, CDx Labs, Covidien LP, Exact Sciences, Fujifilm Medical Systems USA, Inc, Lucid, Lumendi, Medtronic, Olympus America, Inc, and Salix; research support from Cosmo Pharmaceuticals, Covidien, Docbot, Erbe USA Inc, Fujifilm Holdings America Corporation, Ironwood Pharmaceuticals, Inc, Medtronic USA, Inc, Olympus, Salix, and US Endoscopy.

Publication types

LinkOut - more resources